Chronic eosinophilic leukaemia presenting with erythroderma, mild eosinophilia and hyper-IgE: clinical, immunological and cytogenetic features and therapeutic approach. A case report

Acta Haematologica
E GranjoBarbara J Bain

Abstract

A 23-year-old, white male metallurgist presented with pruritic erythematous maculo-papules over the trunk and upper limbs and 6 months later developed erythroderma, eosinophilia and multi-organ dysfunction. A diagnosis of chronic eosinophilic leukaemia was made on the basis of myeloproliferative involvement of both peripheral blood and bone marrow, associated with eosinophilic differentiation and a t(5;12)(q33;p13) translocation. The initial therapeutic approach was interferon alfa-2b plus cytosine arabinoside, for 13 months, followed by hydroxyurea plus vincristine. There was improvement of skin lesions, disappearance of eosinophilia and decrease of serum immunoglobulin E, towards normal values.

Citations

Dec 1, 2007·Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion·Ashutosh KumarAnil Kumar Tripathi
Jan 27, 2007·Current Opinion in Hematology·Ayalew Tefferi, James W Vardiman
Jul 5, 2005·Acta Haematologica·A Tefferi
Dec 14, 2011·Hematology·Amy D Klion
Jul 9, 2004·International Journal of Hematology·Ayalew Tefferi, Animesh Pardanani
Sep 1, 2007·Expert Opinion on Medical Diagnostics·Brijesh Arora, Ayalew Tefferi
Sep 18, 2007·Immunology and Allergy Clinics of North America·Joseph H Butterfield
Jul 9, 2003·British Journal of Haematology·Barbara J Bain
Feb 27, 2009·British Journal of Haematology·Gerald J Gleich, Kristin M Leiferman
Jun 20, 2006·Best Practice & Research. Clinical Haematology·Ayalew Tefferi, Gary Gilliland
Apr 2, 2005·Clinics in Dermatology·Marti Jill RotheJane M Grant-Kels
Apr 14, 2006·Mayo Clinic Proceedings·Ayalew TefferiAnimesh Pardanani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basophils

Basophils are myeloid cells with a high affinity IgE receptor and is involved in inflammatory responses during allergy. Discover the latest research on Basophils here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Allergies & Environmental Factors

Environmental factors are strongly associated with the prevalence of allergies and are an increasing health concern worldwide. Discover the latest research on Allergies and Environmental Factors here.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Related Papers

British Journal of Haematology
Rajeev GuptaBarbara J Bain
British Journal of Haematology
P J van den Anker-Lugtenburg, M B van 't Veer
Cancer Genetics and Cytogenetics
Stéphane LepretreHervé Tilly
The Journal of Allergy and Clinical Immunology
G W CanonicaM Bagnasco
© 2022 Meta ULC. All rights reserved